Natriumklorid Braun 9 mg/ml spädningsvätska för parenteral användning clinical trials

A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and preliminary efficacy of single intraarticular injections of three dose levels of SYN321 and placebo in patients with symptomatic knee osteoarthritis

This study is testing a new medicine, SYN321, for knee osteoarthritis. It's looking at how safe it is, how well people tolerate it, and if it helps with pain, compared to a dummy treatment. We hope to find out if it's a good option for future treatments.